Sunday November 8 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Onchocerciasis

Onchocerciasis or river blindness is the world's second leading infectious cause of blindness. It is caused by Onchocerca volvulus, a Parasitic worm that can live for up to fifteen years in the human body. (From the Wikpedia article Onchocerciasis.)

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Onchocerciasis:

Pubmed Logo
Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November 2008. la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations
Identification of drug resistance before it becomes a public health...
15th October, 2009
Wkly Epidemiol Rec. 2009 Sep 18;84(38):385-9.
Onchocerciasis: elimination is feasible. la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations
Identification of drug resistance before it becomes a public health...
15th October, 2009
Wkly Epidemiol Rec. 2009 Sep 11;84(37):382-3.
Picture this...Onchocerciasis.
Mesothelioma develops most commonly in the pleura, and less frequently in...
10th October, 2009
AFSOC, Hurlburt Field, USA. J Spec Oper Med. 2009 Winter;9(1):136-44.
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness.
Identification of drug resistance before it becomes a public health...
7th October, 2009
Department of Infectious Disease Epidemiology, Imperial College London, Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16716-21. Epub 2009 Sep 17.
DOI Direct Link
Head nodding syndrome and river blindness: a parasitologic perspective.
Identification of drug resistance before it becomes a public health...
2nd October, 2009
Epilepsia. 2009 Oct;50(10):2325-6.
DOI Direct Link

View more research publications.

Onchocerciasis Clinical Trials:

Clinical Trials Logo
Study Evaluating Orally Administered Moxidectin in Subjects With Onchocerca Volvulus Infection

Onchocerciasis Patents:

USPTO Logo
US Patent No.Title
7368527 HADDE71 polypeptides
7411051 Antibodies to HDPPA04 polypeptide
7414062 Triazaspiro compounds useful for treating or preventing pain
7416723 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
7417121 Human G-protein coupled receptor, HGPRBMY39

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Onchocerciasis scientists - we have details of around 366 individuals working on Onchocerciasis .


This page has been viewed 478 times
Recent Search Terms used to find this page: Onchocerca in US | interesting facts about onchocerciasis | recent facts on onchocerciasis | Onchocerciasis river blindness Report from the eighteenth InterAmerican Conference on Onchocerciasis November 2008 | onchocerciasis drug discovery | onchocerciasis facts | publications on Onchocerciasis | Facts about Onchocerciasis | video onchocerca onchocerciasis | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Onchocerciasis across BioPortfolio, or for Onchocerciasis Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.